Manila Water’s 200 million-liter-per-day (MLD) Water Treatment Plant (WTP) under the East Bay Phase 2 project is on track for ...
Merck (NYSE:MRK) and Esai (OTCPK:ESALF) (OTCPK:ESAIY) announced Friday a mixed outcome in their Phase 3 LEAP-015 trial, which was designed to evaluate MRK’s anti-PD-1 therapy Keytruda and the Japanese ...
Merck & Co. and Eisai reported mixed results from a late-stage study of the cancer drugs Keytruda and Lenvima in patients with certain types of gastroesophageal cancer.
Arne Slot's dad wasn't impressed with Liverpool's midweek win over Lille in the Champions League. The Liverpool manager ...